Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam M Bressler

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Clinical Microbiology|March 9, 2004
Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirusAdam M Bressler, Frederick S Nolte
The American Journal of Case Reports|May 10, 2026
Culture-Negative Infective Endocarditis Presenting as ANCA-Positive GlomerulonephritisMohammad Eshaq Kyhan, Adam M Bressler
Journal of the American Podiatric Medical Association|October 21, 2021
Fulminant Septicemia from Aeromonas hydrophilia in a Nonmobile Diabetic PatientSara E Lewis, Devin W Collins, Adam M Bressler
The Lancet. Infectious Diseases|August 4, 2004
Peripheral neuropathy associated with prolonged use of linezolidAdam M Bressler, Shanta M Zimmer, Jane L Gilmore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind studyDaniel M Musher, Nancy Logan, Adam M Bressler, et al.
Drugs - Real World Outcomes|November 8, 2019
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)Adam M Bressler, Ali A Hassoun, Louis D Saravolatz, et al.
Journal of Clinical Microbiology|September 8, 2005
Correlation of penicillin Binding protein 2a detection with oxacillin resistance in Staphylococcus aureus and discovery of a novel penicillin binding protein 2a mutationAdam M Bressler, Teresa Williams, Elizabeth E Culler, et al.
Drugs - Real World Outcomes|May 27, 2021
Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™)Charles R Sims, Adam M Bressler, Donald R Graham, et al.
Infection Control and Hospital Epidemiology|July 11, 2007
Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control studyAdam M Bressler, Keith S Kaye, John J LiPuma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremiaChristopher W Woods, Adam M Bressler, John J LiPuma, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Microbiology|March 9, 2004
Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirusAdam M Bressler, Frederick S Nolte
The American Journal of Case Reports|May 10, 2026
Culture-Negative Infective Endocarditis Presenting as ANCA-Positive GlomerulonephritisMohammad Eshaq Kyhan, Adam M Bressler
Journal of the American Podiatric Medical Association|October 21, 2021
Fulminant Septicemia from Aeromonas hydrophilia in a Nonmobile Diabetic PatientSara E Lewis, Devin W Collins, Adam M Bressler
The Lancet. Infectious Diseases|August 4, 2004
Peripheral neuropathy associated with prolonged use of linezolidAdam M Bressler, Shanta M Zimmer, Jane L Gilmore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind studyDaniel M Musher, Nancy Logan, Adam M Bressler, et al.
Drugs - Real World Outcomes|November 8, 2019
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)Adam M Bressler, Ali A Hassoun, Louis D Saravolatz, et al.
Journal of Clinical Microbiology|September 8, 2005
Correlation of penicillin Binding protein 2a detection with oxacillin resistance in Staphylococcus aureus and discovery of a novel penicillin binding protein 2a mutationAdam M Bressler, Teresa Williams, Elizabeth E Culler, et al.
Drugs - Real World Outcomes|May 27, 2021
Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™)Charles R Sims, Adam M Bressler, Donald R Graham, et al.
Infection Control and Hospital Epidemiology|July 11, 2007
Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control studyAdam M Bressler, Keith S Kaye, John J LiPuma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremiaChristopher W Woods, Adam M Bressler, John J LiPuma, et al.
Pageof 2